Hammoudi Nassim, Verdot Romain, Delorme Jean, Bouam Amar, Drancourt Michel
IHU Méditerranée Infection, Marseille, France.
Aix-Marseille University, IRD, MEPHI, IHU Méditerranée Infection, Marseille, France.
PLoS One. 2020 Aug 6;15(8):e0231685. doi: 10.1371/journal.pone.0231685. eCollection 2020.
Mycobacterium ulcerans, a non-tuberculous mycobacterium responsible for Buruli ulcer, resides in poorly defined environmental niches in the vicinity of stagnant water. Very few isolates have been confirmed. With a view to culturing M. ulcerans from such contaminated environmental specimens, we tested the in vitro susceptibility of the M. ulcerans CU001 strain co-cultivated with XTC cells to anti-infectious molecules registered in the French pharmacopoeia. We used a standardised concentration to identify molecules that were inactive against M. ulcerans and which could be incorporated into a decontaminating solution. Of 116 tested molecules, 64 (55.1%) molecules were ineffective against M. ulcerans CU001. These included 34 (29.3%) antibiotics, 14 (12%) antivirals, eight (6.8%) antiparasitics, and eight (6.8%) antifungals. This left 52 molecules which were active against M. ulcerans CU001. Three of the inactive antimicrobial molecules (oxytetracycline, polymyxin E and voriconazole) were then selected to prepare a decontamination solution which was shown to respect M. ulcerans CU001 viability. These three antimicrobials could be incorporated into a decontamination solution to potentially isolate and culture M. ulcerans from environmental samples.
溃疡分枝杆菌是一种导致布鲁里溃疡的非结核分枝杆菌,栖息于死水附近难以明确界定的环境生态位中。已确认的分离株极少。为了从这类受污染的环境样本中培养溃疡分枝杆菌,我们测试了与XTC细胞共培养的溃疡分枝杆菌CU001菌株对法国药典中登记的抗感染分子的体外敏感性。我们使用标准化浓度来鉴定对溃疡分枝杆菌无活性且可纳入去污溶液的分子。在116种测试分子中,64种(55.1%)分子对溃疡分枝杆菌CU001无效。其中包括34种(29.3%)抗生素、14种(12%)抗病毒药物、8种(6.8%)抗寄生虫药物和8种(6.8%)抗真菌药物。剩下52种分子对溃疡分枝杆菌CU001有活性。然后选择三种无活性的抗菌分子(土霉素、多粘菌素E和伏立康唑)来制备一种去污溶液,结果表明该溶液能保持溃疡分枝杆菌CU001的活力。这三种抗菌药物可纳入去污溶液中,以便从环境样本中潜在地分离和培养溃疡分枝杆菌。